eMagin Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for eMagin in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" eMagin stock.
View analyst ratings for eMagin or view top-rated stocks.

Wall Street analysts have given eMagin a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but eMagin wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

eMagin saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 868,000 shares, an increase of 72.0% from the January 28th total of 504,700 shares. Based on an average trading volume of 2,100,000 shares, the short-interest ratio is currently 0.4 days.
View eMagin's Short Interest.

eMagin is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for eMagin.

eMagin Co. (NYSEAMERICAN:EMAN) released its quarterly earnings data on Thursday, August, 13th. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.04. The semiconductor company earned $7.70 million during the quarter, compared to analyst estimates of $7.50 million. eMagin had a negative trailing twelve-month return on equity of 26.05% and a negative net margin of 27.29%. During the same quarter in the prior year, the firm posted ($0.03) EPS.
View eMagin's earnings history.

eMagin's stock was trading at $0.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EMAN shares have increased by 1,484.0% and is now trading at $3.96.
View which stocks have been most impacted by COVID-19.

Some companies that are related to eMagin include Maxeon Solar Technologies (MAXN), Ichor (ICHR), ChipMOS TECHNOLOGIES (IMOS), Alpha and Omega Semiconductor (AOSL), Photronics (PLAB), Kopin (KOPN), MagnaChip Semiconductor (MX), Ebang International (EBON), Atomera (ATOM), ReneSola (SOL), AXT (AXTI), NeoPhotonics (NPTN), DSP Group (DSPG), NVE (NVEC) and POET Technologies (POETF).
View all of EMAN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other eMagin investors own include Guyana Goldfields Inc. (GUY.TO) (GUY), Hawkins (HWKN), CA (CA), Kopin (KOPN), Universal Display (OLED), Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), Riot Blockchain (RIOT), BlackRock (BLK) and Advanced Micro Devices (AMD).

eMagin trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "EMAN."

eMagin's stock is owned by a number of retail and institutional investors. Top institutional shareholders include GSA Capital Partners LLP (0.49%), Virtu Financial LLC (0.19%), JBF Capital Inc. (0.17%), Northern Trust Corp (0.16%), Renaissance Technologies LLC (0.14%) and Bank of New York Mellon Corp (0.08%). Company insiders that own eMagin stock include Eric Braddom, Ltd Ginola, Mark A Koch and Stillwater Holdings Llc.
View institutional ownership trends for eMagin.

EMAN stock was sold by a variety of institutional investors in the last quarter, including Private Capital Advisors Inc., and Northern Trust Corp. Company insiders that have sold eMagin company stock in the last year include Ltd Ginola, and Stillwater Holdings Llc.
View insider buying and selling activity for eMagin or view top insider-selling stocks.

EMAN stock was bought by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Renaissance Technologies LLC, Virtu Financial LLC, Bank of New York Mellon Corp, JBF Capital Inc., BlackRock Inc., and IFP Advisors Inc. Company insiders that have bought eMagin stock in the last two years include Eric Braddom, and Mark A Koch.
View insider buying and selling activity for eMagin or or view top insider-buying stocks.

Shares of EMAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EMAN stock can currently be purchased for approximately $3.96.

eMagin has a market capitalization of $267.30 million and generates $26.73 million in revenue each year. The semiconductor company earns $-4,300,000.00 in net income (profit) each year or ($0.09) on an earnings per share basis.

eMagin employs 94 workers across the globe.

The official website for eMagin is www.emagin.com.

eMagin is headquartered at 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States.

eMagin's mailing address is 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States. The semiconductor company can be reached via phone at +1-845-8387900 or via email at [email protected]